Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
39 studies found for:    neurology AND university of california, san francisco | Open Studies
Show Display Options
Rank Status Study
1 Recruiting A TSEC for Symptom Management in Menopausal Women With Multiple Sclerosis
Conditions: Menopause;   Multiple Sclerosis
Interventions: Drug: Tissue Selective Estrogen Complex;   Drug: Placebo
2 Recruiting Brain Development Research Program
Conditions: Brain Disorders;   Aicardi Syndrome
Intervention:
3 Not yet recruiting High-dose Erythropoietin for Asphyxia and Encephalopathy
Conditions: Neonatal Encephalopathy;   Birth Asphyxia
Interventions: Drug: Normal saline placebo;   Drug: erythropoietin
4 Recruiting Clinical Characteristics of Dementias That Occur Remotely After Traumatic Brain Injury in Retired Military Personnel
Conditions: Dementia;   Traumatic Brain Injury (TBI);   Mild Cognitive Impairment (MCI);   Chronic Traumatic Encephalopathy (CTE);   Post-traumatic Stress Disorder (PTSD)
Intervention:
5 Recruiting Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects
Condition: Familial Frontotemporal Dementia
Intervention:
6 Recruiting A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
Condition: AADC Deficiency
Intervention: Drug: AAV2-hAADC
7 Recruiting Efficacy of Web-Based Social-Cognitive Interventions in Right Hemisphere Stroke and Frontotemporal Dementia
Conditions: Frontotemporal Dementia;   Right Sided Cerebral Hemisphere Cerebrovascular Accident
Intervention: Other: Brain HQ
8 Recruiting Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis
Condition: Pediatric Multiple Sclerosis
Intervention:
9 Recruiting Vitamin D Supplementation in Multiple Sclerosis
Condition: Relapsing Remitting Multiple Sclerosis
Intervention: Drug: Vitamin D3
10 Recruiting A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome
Conditions: Dravet Syndrome;   Seizure Disorder
Interventions: Drug: ZX008 (Fenfluramine Hydrochloride);   Drug: Matching Placebo
11 Recruiting The Human Epilepsy Project
Condition: Focal Epilepsy
Intervention:
12 Not yet recruiting Effect of MD1003 in Progressive Multiple Sclerosis (SPI2)
Condition: Multiple Sclerosis
Interventions: Drug: MD1003 100mg capsule;   Drug: PLACEBO
13 Recruiting Analysis of Telmisartan Administered With Antiretroviral Therapy (ART) in Patients With Acute HIV Infection
Conditions: Acute HIV Infection;   HIV Infections
Intervention: Drug: Telmisartan
14 Recruiting Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3) Protocol
Conditions: Mild Cognitive Impairment (MCI);   Alzheimer's Disease (AD)
Intervention:
15 Recruiting CENTER-TBI: Collaborative European NeuroTrauma Effectiveness Research in TBI
Condition: Traumatic Brain Injury
Intervention:
16 Recruiting Deep Brain Stimulation (DBS) for the Treatment of Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Device: Deep Brain Stimulation
17 Recruiting Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations
Condition: Cryptogenic Sensory Polyneuropathy
Interventions: Drug: Nortriptyline;   Drug: Duloxetine;   Drug: Pregabalin;   Drug: Mexiletine
18 Recruiting Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Conditions: Transthyretin Mutations;   Transthyretin Amyloidosis
Intervention: Other: None. Observational Study.
19 Recruiting Phenotype, Genotype & Biomarkers in ALS and Related Disorders
Conditions: Amyotrophic Lateral Sclerosis;   Frontotemporal Dementia;   Primary Lateral Sclerosis;   Hereditary Spastic Paraplegia;   Progressive Muscular Atrophy;   Multisystem Proteinopathy
Intervention:
20 Recruiting Pediatric Open-Label Extension Study
Conditions: Schizophrenia;   Autism;   Bipolar Depression
Intervention: Drug: Lurasidone 20, 40, 60, 80 mg, flexibly dosed

   Previous Page Studies Shown (1-20) Next Page (21-39) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.